LC Luxuries announces acquisition of domain name CannaCare.com

LC LUXURIES LIMITED (Pink Sheets:LLUX) (the "Company") today announced that it has acquired the domain name CannaCare.com and will begin developing CannaCare.com as its nationwide physician marketing engine as it relates to the cannabis industry. Development is underway and the Company anticipates the site operational by the end of the year. Bonni Goldstein, MD, a board member for LC Luxuries Limited, will be materially involved with the content and direction of CannaCare.com.

Dr. Goldstein states: "The information available to the public today about the application of medicinal cannabis is fragmented and confusing. Our goal is to consolidate accurate information and provide a website that is relevant, informative, educational and objective."

Doug Francis, CEO of the Company, states: "CannaCare.com will focus on premium content designed for patients who are learning about medical cannabis, a basically untouched segment in the industry. Through CannaCare.com, we are confident Dr. Goldstein will create content that will be the gateway for thousands of patients, healthcare providers and individuals seeking clarity about cannabis."

Jim Pakulis, President of the Company, concurs: "CannaCare.com is a significant piece of our cannabis internet vertical. We are excited to have the opportunity to build a system that is educational for the consumer and beneficial to our shareholders."

Source LC Luxuries Limited

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DNA changes from high potency cannabis use may signal psychosis risk